2025 Regular Session • Indiana Legislature
HB1065: Cancer clinical trial program.
Legislative Summary
Cancer clinical trial program. Allows an organization or entity to establish and administer a cancer clinical trial participation program for the purpose of providing payments to a participant for certain costs incurred by the participant while participating in a cancer clinical trial. Sets forth program requirements and participant eligibility.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/8/2025
Authored by Representative Shackleford
House of Representatives
1/8/2025
First reading: referred to Committee on Public Health
House of Representatives
1/27/2025
Representative Aylesworth added as coauthor
House of Representatives
2/11/2025
Committee report: amend do pass, adopted
House of Representatives
2/13/2025
Second reading: ordered engrossed
House of Representatives
2/17/2025
Representative Aylesworth removed as coauthor
House of Representatives
2/17/2025
Senate sponsors: Senators Charbonneau, Crider, Yoder
House of Representatives
2/17/2025
Cosponsor: Senator Jackson
House of Representatives
2/17/2025
Third reading: passed; Roll Call 166: yeas 95, nays 0
House of Representatives
2/17/2025
Representatives Barrett, Aylesworth, Porter added as coauthors
House of Representatives
2/18/2025
Referred to the Senate
House of Representatives
3/3/2025
First reading: referred to Committee on Health and Provider Services
Senate
3/13/2025
Committee report: do pass, adopted
Senate
3/17/2025
Second reading: ordered engrossed
Senate
3/18/2025
Third reading: passed; Roll Call 242: yeas 49, nays 0
Senate
3/18/2025
Senator Randolph added as cosponsor
Senate
3/19/2025
Returned to the House without amendments
Senate
3/20/2025
Signed by the Speaker
House of Representatives
3/24/2025
Signed by the President Pro Tempore
Senate
3/27/2025
Signed by the President of the Senate
Senate
4/3/2025
Signed by the Governor
House of Representatives
Amendments
House Public Health Amendment #1
House Public Health Amendment #1
2/11/2025Not Adopted
Roll Call Votes
Senate - Third reading
3/18/2025
49
Yea
0
Nay
0
Not Voting
1
Absent
Result: PASSED
House - Third reading
2/17/2025
95
Yea
0
Nay
1
Not Voting
4
Absent
Result: PASSED
Status Information
Current Status
Passed(4/3/2025)
Chamber
House of Representatives
